Page last updated: 2024-11-04

rofecoxib and Infertility, Male

rofecoxib has been researched along with Infertility, Male in 1 studies

Infertility, Male: The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility.

Research Excerpts

ExcerptRelevanceReference
" We evaluated the effects of treatment with rofecoxib, a cyclooxygenase-2 inhibitor, on sperm quality and pregnancy rate after intrauterine insemination (IUI) or monitored intercourse."3.74Sperm quality and pregnancy rate after COX-2 inhibitor therapy of infertile males with abacterial leukocytospermia. ( De Leo, V; Focarelli, R; Gambera, L; Morgante, G; Piomboni, P; Serafini, F, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gambera, L1
Serafini, F1
Morgante, G1
Focarelli, R1
De Leo, V1
Piomboni, P1

Other Studies

1 other study available for rofecoxib and Infertility, Male

ArticleYear
Sperm quality and pregnancy rate after COX-2 inhibitor therapy of infertile males with abacterial leukocytospermia.
    Human reproduction (Oxford, England), 2007, Volume: 22, Issue:4

    Topics: Adult; Cyclooxygenase 2; Female; Humans; Infertility, Male; Lactones; Leukocytes; Male; Pregnancy; P

2007